Literature DB >> 33604862

Outcomes of Infection and Risk of Mortality in Liver Transplant Patients with Simultaneous Splenectomy.

Hsiu-Lung Fan1, Chung-Bao Hsieh1, Hao-Ming Chang1, Ning-Chi Wang2, Ya-Wen Lin3, Teng-Wei Chen4.   

Abstract

PURPOSE: The purpose of this study was to compare the outcomes of infection between liver transplant patients with and without simultaneous splenectomy.
METHODS: We retrospectively analyzed the records of 211 patients who underwent liver transplantation in the Tri-Service General Hospital from 2012 to 2017. The frequency of blood cultures obtained after liver transplantation; incidence of bacteremia, pathogens, and complications; and overall survival rates were compared between the groups.
RESULTS: One hundred thirty-three of 211 patients underwent liver transplantation without simultaneous splenectomy. There were no significant differences in the frequency of blood cultures obtained after liver transplantation (non-splenectomy group and splenectomy group: 63% and 62%, respectively); incidences of bacteremia after liver transplantation (21% and 21%, respectively), repeat bacteremia (39% and 35%, respectively), cytomegalovirus infection (4% and 3%, respectively), herpes infection (6% and 7%, respectively), and fungal infection (3% and 3%, respectively); and overall survival rate between the two groups. However, there was a significant difference in infection-related deaths between the groups. Simultaneous splenectomy and episodes of antibody-related rejection were significant risk factors associated with infection-related death in multivariate analyses.
CONCLUSION: Although simultaneous splenectomy does not increase the incidence of infection, simultaneous splenectomy definitely carries risks of infection-related mortality in liver transplantation.

Entities:  

Keywords:  Infectious disease; Liver transplantation; Spleen

Year:  2021        PMID: 33604862     DOI: 10.1007/s11605-021-04914-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  4 in total

1.  Using low graft/recipient's body weight ratio graft with portal flow modulation an effective way to prevent small-for-size syndrome in living-donor liver transplant: a retrospective analysis.

Authors:  Bhavin Vasavada; Chao Long Chen; Muhammad Zakaria
Journal:  Exp Clin Transplant       Date:  2014-10       Impact factor: 0.945

2.  Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?

Authors:  Roberto Troisi; Guy Cammu; Giuseppe Militerno; Luc De Baerdemaeker; Johan Decruyenaere; Eric Hoste; Peter Smeets; Isabelle Colle; Hans Van Vlierberghe; Mirko Petrovic; Dirk Voet; Eric Mortier; Uwe J Hesse; Bernard de Hemptinne
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

3.  Liver lobe graft side and outcomes in living-donor liver transplant with small-for-size grafts.

Authors:  Karan D Julka; Chao-Long Chen; Bhavin Vasavada
Journal:  Exp Clin Transplant       Date:  2014-08       Impact factor: 0.945

4.  Splenic Artery Embolization in Patients After Orthotopic Liver Transplant.

Authors:  Myltykbay Rysmakhanov; Marlen Doskali; Aliya Taganova; Aidos Kulmagambetov; Aibolat Smagulov; Akhmet Seidakhmetov; Abay Baigenzhin; Zhaksylyk Doskaliyev
Journal:  Exp Clin Transplant       Date:  2015-11       Impact factor: 0.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.